1 December 2011 in Otology & Neurotology
Objectives This study aimed to investigate the therapeutic efficacy of intratympanic dexamethasone (ITD) as a salvage treatment in sudden hearing loss (SHL) patients who had no response to initial systemic combination steroid therapy. Patients and Methods From May 2007 to June 2010, 415 SHL patients visited 3 tertiary referral centers within 7 days of disease onset. They were all treated with an identical protocol, a 10-day scheduled hospitalization and oral steroid treatment. Of these, 151 patients were totally unresponsive 2 weeks after treatment initiation according to Siegel’s criteria. We divided these 151 refractory patients into 3 groups: those receiving no further treatment (control group, n = 59), those receiving one more 10-day cycle of oral steroids (systemic reapplication group, n = 26), and those receiving ITD therapy (ITD group, n = 66). Final assessment of hearing was conducted approximately 3 months after the onset of SHL. Hearing improvement was defined as demonstrating “any” improvement according to Siegel’s criteria. Results The initial average hearing thresholds of all groups were similar. Overall hearing improvement was observed in 10 of 59 patients in the control group, in 4 of 26 in the systemic reapplication group, and in 32 of 66 in the ITD group. No serious complications were observed. Analyzing by frequency, paradoxically, hearing of the low and mid frequencies was more significantly improved than high frequencies in the ITD group. Conclusion Intratympanic dexamethasone administration after failure of an initial treatment is effective, and this should be used as a salvage treatment in cases of refractory SHL.
22 November 2011 in The Laryngoscope
1 January 2009 in Acta Oto-Laryngologica
Conclusion: Posterior canal reconstruction using autogenous bone pate and mastoid obliteration with allogenous cancellous bone chips (ACBCs) is a useful method to eliminate cavity problems after canal wall down tympanomastoidectomy (CWDT). It is also an appropriate method to obtain adequate middle ear space for hearing gain and to apply hearing aids for patients with poor eustachian tube function after surgery. Objective: This study was performed to suggest a new technique for posterior canal reconstruction and mastoid obliteration and to evaluate the outcome of the surgery. Patients and methods: The entire posterior canal was reconstructed with autogenous bone pate, and the new isolated mastoid cavity was obliterated with ACBCs in patients who had undergone CWDT and suffered from cavity problems. Outcomes were measured by external auditory canal shape, condition of the neotympanum, hearing outcome, improvement of cavity problems, and surgical complications. Results: In 90.9%, the reconstructed canal wall maintained a cylindrical shape. The drum healed without perforation/retraction in 90.9%. The average air–bone gap value was 34.5 dB hearing level (HL) before the staged operation and 17.8 dB HL after the staged operation; 95.5% had no more cavity problems. Minor postauricular wound infection was the most common complication (13.6%).
1 July 2014 in The Laryngoscope
1 January 2012 in Yonsei Medical Journal
Kim J, et al. Yonsei Med J. 2012 May;53(3):642-648. https://doi.org/10.3349/ymj.2012.53.3.642